BCL2L12 and neoplasm: As mere expression of the anti-apoptotic target proteins has not been clearly demonstrated to predict response to BH3-mimetic treatment, we investigated the expression of the recently suggested predictive biomarkers BCL2L12 and BBC3 for paediatric tumours [31].